Triphenylphosphine → HCID 24992097, compound
Reaction equation
[OH:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][C:11]([S:14]([NH:17][CH2:18][CH2:19][NH:20][C:21](=[O:27])[O:22][C:23]([CH3:26])([CH3:25])[CH3:24])(=[O:16])=[O:15])=[CH:10][CH:9]=2)=[CH:4][CH:3]=1.[CH3:28][CH:29]([C:31]1[N:35]=[C:34]([N:36]2[CH2:41][CH2:40][CH:39]([CH2:42]O)[CH2:38][CH2:37]2)[O:33][N:32]=1)[CH3:30].C1C=CC(P(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.N(C(OC(C)C)=O)=NC(OC(C)C)=O>C1COCC1>[CH3:30][CH:29]([C:31]1[N:35]=[C:34]([N:36]2[CH2:37][CH2:38][CH:39]([CH2:42][O:1][C:2]3[CH:7]=[CH:6][C:5]([C:8]4[CH:9]=[CH:10][C:11]([S:14]([NH:17][CH2:18][CH2:19][NH:20][C:21](=[O:27])[O:22][C:23]([CH3:24])([CH3:26])[CH3:25])(=[O:15])=[O:16])=[CH:12][CH:13]=4)=[CH:4][CH:3]=3)[CH2:40][CH2:41]2)[O:33][N:32]=1)[CH3:28]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
The title compound (169 mg, 45%) was prepared as a white solid from 1,1-dimethylethyl (2-{[(4′-hydroxy-4-biphenylyl)sulfonyl]amino}ethyl)carbamate (246 mg, 0.63 mmol), {1-[3-(1-methylethyl)-1,2,4-oxadiazol-5-yl]-4-piperidinyl}methanol (prepared as in Example 20, Step 3, 214 mg, 0.95 mmol) and Ph3P (249 mg, 0.95 mmol) in THF (5 mL) followed by diisopropyl azodicarboxylate (0.187 mL, 0.95 mmol) in a manner similar to Example 1, Step 2. 1H NMR (400 MHz, DMSO-d6) δ 7.84-7.72 (m, 4H), 7.70-7.60 (m, 3H), 7.03 (d, 2H, J=8.8 Hz), 6.76 (t, 1H, J=5.4 Hz), 4.03-3.91 (m, 2H), 3.90 (d, 2H, J=6.4 Hz), 3.15-3.05 (m, 2H), 2.98-2.88 (m, 2H), 2.83-2.67 (m, 3H), 2.06-1.94 (m, 1H), 1.89-1.79 (m, 2H), 1.38-1.24 (m, 11H), 1.14 (d, 6H, J=7.0 Hz); LRMS (ESI), m/z 600 (M+H).
Sources & evidence
- ORD record
- ord-27f98098fc004f60912e416e509c2bc6
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08101634B2
Reaction notes
Loading…